Skip to main content
Clinical Trials/NCT00890864
NCT00890864
Completed
N/A

Pilot Study of the Feasibility and Acceptability of Randomising the phasing-in of the Age Extension of the NHS Breast Screening Programme in England

University of Oxford0 sites36,000 target enrollmentMay 2009

Overview

Phase
N/A
Intervention
Not specified
Conditions
Routine Mammography
Sponsor
University of Oxford
Enrollment
36000
Primary Endpoint
Screening uptake among women invited for screening in the extended age groups
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

The purpose of this pilot study is to assess the feasibility and acceptability of randomising the phasing-in of the age extension of the NHS Breast Screening Programme in six volunteer sites in different areas of England.

Detailed Description

Currently all women are invited for breast screening between the ages of 50 and 70. In 2007 the Cancer Reform Strategy announced that from 2012 the NHS Breast Screening Programme would be extended to cover women between the ages of 47 and 73. This means that all women will get two extra screening invitations in their lifetime. It also means that all women will get their first invitation before age 50. As capacity does not allow for full immediate roll out across the whole of England, the age extension will be phased-in with full coverage from 2012. Randomising this phasing-in would provide unbiased evidence on the extent to which it is beneficial to extend the age range for breast screening and whether an extra screen at younger or older ages is more worthwhile. To date there is no clear evidence on this as no trial has looked at the added value of one extra screen within an existing screening programme. This pilot study will assess the feasibility and acceptability of randomising the phasing-in of the age extension in six volunteer sites in different areas of England.

Registry
clinicaltrials.gov
Start Date
May 2009
End Date
May 2010
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • female, and living in one of the 6 pilot areas, and
  • aged 47-49 or 71-73 years, and
  • in a screening invitation batch that includes their age group.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Screening uptake among women invited for screening in the extended age groups

Time Frame: One year

Secondary Outcomes

  • Workload associated with inviting these new age groups for screening(One year)
  • Self-referrals among women in the pilot areas aged 47-49 or 71-73 but who were not invited for screening(One year)

Similar Trials